Total Payments
$777,730
2024 Payments
$215,787
Companies
21
Transactions
938
Medicare Patients
1,065
Medicare Billing
$107,465
Payment Breakdown by Category
Other$647,452 (83.2%)
Travel$96,903 (12.5%)
Food & Beverage$22,002 (2.8%)
Consulting$11,360 (1.5%)
Education$13.22 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $258,364 | 70 | 33.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $216,288 | 52 | 27.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $172,800 | 60 | 22.2% |
| Travel and Lodging | $96,903 | 342 | 12.5% |
| Food and Beverage | $22,002 | 407 | 2.8% |
| Consulting Fee | $11,360 | 5 | 1.5% |
| Education | $13.22 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $566,790 | 660 | $0 (2024) |
| GENZYME CORPORATION | $95,954 | 62 | $0 (2024) |
| ABBVIE INC. | $56,850 | 109 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $26,342 | 40 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $24,496 | 20 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $6,280 | 11 | $0 (2024) |
| RedHill Biopharma Inc. | $176.03 | 9 | $0 (2023) |
| Medtronic, Inc. | $165.50 | 2 | $0 (2021) |
| Covidien LP | $154.22 | 2 | $0 (2020) |
| Exact Sciences Corporation | $119.32 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $215,787 | 232 | GENZYME CORPORATION ($94,417) |
| 2023 | $95,481 | 133 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($93,803) |
| 2022 | $91,931 | 87 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($77,864) |
| 2021 | $123,172 | 139 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($120,749) |
| 2020 | $14,771 | 45 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($12,418) |
| 2019 | $116,933 | 140 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($112,252) |
| 2018 | $74,563 | 104 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($61,142) |
| 2017 | $45,092 | 58 | Valeant Pharmaceuticals North America LLC ($24,496) |
All Payment Transactions
938 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $21.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,725.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $728.98 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $399.23 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $138.19 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $109.95 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | Cash or cash equivalent | $90.20 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $46.00 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $81.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $275.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | Cash or cash equivalent | $14.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,725.00 | General |
| Category: Immunology | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $595.96 | General |
| Category: Immunology | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $92.09 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,329.00 | General |
| Category: Immunology | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $392.62 | General |
| Category: Immunology | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $202.40 | General |
| Category: Immunology | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $48.71 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | Cash or cash equivalent | $26.35 | General |
| Category: Immunology | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,329.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 194 | 201 | $83,537 | $17,658 |
| 2022 | 7 | 200 | 206 | $93,220 | $19,865 |
| 2021 | 11 | 297 | 316 | $155,499 | $30,208 |
| 2020 | 11 | 374 | 403 | $196,558 | $39,735 |
Total Patients
1,065
Total Services
1,126
Medicare Billing
$107,465
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 41 | 41 | $35,178 | $7,704 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 75 | 80 | $11,600 | $3,615 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 28 | 30 | $6,300 | $2,091 | 33.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $12,992 | $1,801 | 13.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $14,763 | $1,634 | 11.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 13 | 13 | $2,704 | $812.94 | 30.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 39 | 40 | $34,320 | $7,717 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 56 | 60 | $8,700 | $2,954 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 32 | 33 | $6,930 | $2,450 | 35.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 26 | 26 | $18,278 | $2,183 | 11.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $12,180 | $2,069 | 17.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 19 | 19 | $10,108 | $1,632 | 16.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 13 | 13 | $2,704 | $859.40 | 31.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 38 | 38 | $42,324 | $7,527 | 17.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 52 | 62 | $14,570 | $4,883 | 33.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 45 | 47 | $34,545 | $3,642 | 10.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 22 | 22 | $22,000 | $2,572 | 11.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 24 | 24 | $7,272 | $2,561 | 35.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 22 | 22 | $7,942 | $2,366 | 29.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 12 | $5,376 | $1,686 | 31.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 32 | 32 | $5,105 | $1,642 | 32.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 15 | $3,885 | $1,042 | 26.8% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 12 | 12 | $7,605 | $954.47 | 12.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 15 | 15 | $3,570 | $923.40 | 25.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 11 | 15 | $1,305 | $408.80 | 31.3% |
About Dr. Conar Fitton, M.D
Dr. Conar Fitton, M.D is a Internal Medicine healthcare provider based in Kenner, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1316182744.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Conar Fitton, M.D has received a total of $777,730 in payments from pharmaceutical and medical device companies, with $215,787 received in 2024. These payments were reported across 938 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($258,364).
As a Medicare-enrolled provider, Fitton has provided services to 1,065 Medicare beneficiaries, totaling 1,126 services with total Medicare billing of $107,465. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology, Gastroenterology
- Location Kenner, LA
- Active Since 12/15/2008
- Last Updated 11/14/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1316182744
Products in Payments
- XIFAXAN (Drug) $370,950
- RELISTOR (Drug) $139,716
- DUPIXENT (Biological) $102,038
- TRULANCE (Drug) $51,728
- VOQUEZNA (Drug) $26,342
- Humira (Biological) $23,515
- PLENVU (Drug) $19,475
- SKYRIZI (Biological) $8,325
- DOPTELET (Drug) $7,293
- HUMIRA (Biological) $4,513
- RINVOQ (Biological) $3,423
- Talicia (Drug) $176.03
- GI Genius (Device) $149.68
- EndoFlip (Device) $123.14
- Cologuard Collection Kit (Device) $119.32
- LINX Reflux Management System (Device) $92.72
- LINZESS (Drug) $72.73
- ENTYVIO (Biological) $69.46
- Linzess (Drug) $54.35
- Donnatal (Drug) $36.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kenner
Scott Simeon, M.d, M.D
Internal Medicine — Payments: $23,675
Internal Medicine $23,675
Jose Barrientos Paz
Internal Medicine — Payments: $10,381
Internal Medicine $10,381
Sanjin Tunovic, M.d, M.D
Internal Medicine — Payments: $7,994
Internal Medicine $7,994
Najy Masri, Md, MD
Internal Medicine — Payments: $7,230
Internal Medicine $7,230
Anjuman Ara, Md, MD
Internal Medicine — Payments: $1,503
Internal Medicine $1,503
Betty Lo, Md, MD
Internal Medicine — Payments: $996.86
Internal Medicine $996.86